• Home
  • About
  • Contributors
  • Terms of Use
  • Subscribe
facebook
twitter
  • About
  • Blog
  • Contributors
  • Subscribe To Blog
  • Terms of Use
  • What is Medication Therapy Management?

The Potential Benefits and Risks of Cannabis as Medical Treatment

February 16, 2016
by Kenneth Dandurand RPh, M.S.
0 Comment

It is important to examine both the potential benefits and adverse effects when considering the use of cannabis medicinally. Although the FDA has approved only two cannabinoids, several states have approved the legal use of cannabis for medical and/or recreational use. The FDA-approved cannabinoids, dronabinol and nabilone, are indicated for use in chemotherapy-induced nausea. Dronabinol is also used to treat anorexia (wasting syndrome) in AIDS patients. The use of these drugs in treating nausea is somewhat limited because they are only available in oral capsules, but there is an ongoing clinical trial for an oral mucosal spray that might improve absorption.

Marijuana and other cannabinoids can be used to treat symptoms associated with conditions like glaucoma, epilepsy, and chronic pain—but controlled research on their effectiveness has been limited. The initial trials of smoking cannabis for pain relief have been small (50 or fewer patients), although the results are promising. In some studies, smoking cannabis improved caloric intake leading to weight gain in both healthy and HIV-infected patients. For glaucoma, cannabinoids generally do not have as good of treatment outcomes as other medications. In refractory epilepsy, there have been small-scale observational studies, but the mechanism of cannabinoid effects on seizures needs to be further researched. 

One potential long-term consequence of heavy marijuana use is its effect on brain development, namely impaired memory and cognition problems; this is mainly a concern in adolescents. Additionally, as with any substance, there is potential for developing dependency or addiction. The dependency is mostly a psychological one, but physical withdrawal symptoms such as irritability, sleeping difficulties, and anxiety can certainly occur. There have also been links between marijuana use and certain psychological illnesses, namely anxiety and depression, but again, more research needs to be done before this can be confirmed. Smoking marijuana can cause inflammation of the lungs and does contain carcinogens. One solution to this issue is to consider other possible routes of administration, such as edible marijuana.

While these risks remain, marijuana may prove helpful in a host of conditions in the future. In any case, it is important to evaluate patients individually to decide whether or not a certain cannabinoid may be a good treatment option for them. For many, the benefits may certainly outweigh the risks.

SUBSCRIBE
About the Author
Kenneth Dandurand Co-founder/Chief Executive Officer of Clinical Pharmacy Associates, Inc. and President of MedNovations, Inc., received his B.S. in Pharmacy from Northeastern University, Boston, and completed graduate training in hospital pharmacy and business management from Oregon State University and an ASHP-approved residency at Good Samaritan Hospital in Portland, Oregon. Read More About Author
Social Share
  • google-share

Leave a Reply Cancel reply

*
*

DRUGS-facebook
TAKE OUR SHORT SURVEY

White Papers

  • After-Hours Pharmacy Service Models in U.S. Hospitals
  • Reducing Medication-Use Risk
  • Health Information Technology: Can it really save money and improve quality? The need for strategy
  • Improving clinical outcomes and reducing health care costs under the Affordable Care Act - are enhanced medication management strategies part of the solution?
  • Commentary: The Dabigatran Dilemma
  • Commentary: A Prescription for Accountable Healthcare

Recent Posts

IBD Treatment Today: Biologics Are Promising
May 04, 2016
Drug Therapy: Changing and Saving Lives
Apr 08, 2016
Update on Battle Against Opioid Abuse
Mar 24, 2016
Copyright © 2016 Mednovate